October 05, 2015
A California federal judge on Monday granted Allergan Inc.'s motion for summary judgment in a $600 million breach-of-contract lawsuit over Botox, holding that the pharmaceutical giant does not have to pay Miotox certain royalties under the terms of a license agreement.
August 17, 2015
A California federal judge on Monday tentatively ruled Allergan Inc. owes Miotox LLC royalties on Botox only when it's used in migraine treatments covered by Miotox patents, a ruling that would stop Miotox from collecting the $600 million it says it's owed on their royalty agreement.
May 05, 2015
A California federal judge refused Tuesday to dismiss patent-related counterclaims Allergan Inc. filed after Miotox LLC alleged it owed $600 million for breaching a royalty deal over patents for Botox used to treat migraine headaches.
November 12, 2014
Allergan Inc. on Monday slapped Miotox LLC with counterclaims alleging one of its patents for Botox used to treat migraine headaches is invalid and that it isn't infringing other patents, after Miotax alleged Allergan owes it $600 million for breaching a royalty deal.